A low concentration of ouabain (0.18 μg/kg) enhances hypertension in spontaneously hypertensive rats by inhibiting the Na+ pump and activating the renin-angiotensin system

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 8, 2010, Pages 767-776

  Siman, F D M ^a   Stefanon, I ^a   Vassallo, D V ^a,b   Padilha, A S ^a  

^a FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^b Escola Superior de Ciencias da Santa Casa de Misericordia de Vitoria   (Brazil)

Author keywords

Hypertension; Ouabain; Renin angiotensin system

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CANRENONE; ENALAPRIL MALEATE; HEXAMETHONIUM; HYPERTENSIVE FACTOR; LOSARTAN; OUABAIN; PHENYLEPHRINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DRUG EFFECT; DRUG INDUCED DISEASE; HEART LEFT VENTRICLE CONTRACTION; HYPERTENSION; LOW DRUG DOSE; MALE; NONHUMAN; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

RATTUS; STROPHANTHUS GRATUS;

EID: 77957140999     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2010007500061     Document Type: Article

References (32)

1. Buckalew VM Jr, Martinez FJ, Green WE. The effect of dialysates and ultrafiltrates of plasma of saline-loaded dogs on toad bladder sodium transport. J Clin Invest 1970; 49: 926-935.
2. Hamlyn JM, Blaustein MP, Bova S, DuCharme DW, Harris DW, Mandel F, et al. Identification and characterization of a ouabain-like compound from human plasma. Proc Natl Acad Sci U S A 1991; 88: 6259-6263.
3. Mathews WR, DuCharme DW, Hamlyn JM, Harris DW, Mandel F, Clark MA, et al. Mass spectral characterization of an endogenous digitalislike factor from human plasma. Hypertension 1991; 17: 930-935.
4. Goto A, Yamada K, Ishii M, Sugimoto T. Digitalis-like activity in human plasma: relation to blood pressure and sodium balance. Am J Med 1990; 89: 420-426.
5. Manunta P, Stella P, Rivera R, Ciurlino D, Cusi D, Ferrandi M, et al. Left ventricular mass, stroke volume, and ouabainlike factor in essential hypertension. Hypertension 1999; 34: 450-456.
6. Overbeck HW, Pamnani MB, Akera T, Brody TM, Haddy FJ. Depressed function of a ouabain-sensitive sodiumpotassium pump in blood vessels from renal hypertensive dogs. Circ Res 1976; 38: 48-52.
7. Hamlyn JM, Hamilton BP, Manunta P. Endogenous ouabain, sodium balance and blood pressure: a review and a hypothesis. J Hypertens 1996; 14: 151-167.
8. Yuan CM, Manunta P, Hamlyn JM, Chen S, Bohen E, Yeun J, et al. Long-term ouabain administration produces hypertension in rats. Hypertension 1993; 22: 178-187.
9. Rossoni LV, Pinto VD, Vassallo DV. Effects of small doses of ouabain on the arterial blood pressure of anesthetized hypertensive and normotensive rats. Braz J Med Biol Res 2001; 34: 1065-1077.
10. +-ATPase in ouabain-induced hypertension. Br J Pharmacol 2002; 135: 771-781.
11. Blaustein MP. Physiological effects of endogenous ouabain: control of intracellular Ca2+ stores and cell responsiveness. Am J Physiol 1993; 264: C1367-C1387.
12. Vassallo DV, Songu-Mize E, Rossoni LV, Amaral SM. Effects of ouabain on vascular reactivity. Braz J Med Biol Res 1997; 30: 545-552.
13. Barker LA, Rossoni LV, Vassallo DV. Acute pressor actions of ouabain do not enhance the actions of phenylephrine or norepinephrine in anesthetized rats. J Cardiovasc Pharmacol 2001; 37: 339-348.
14. Huang BS, Leenen FH. Brain renin-angiotensin system and ouabain-induced sympathetic hyperactivity and hypertension in Wistar rats. Hypertension 1999; 34: 107-112.
15. Cheung WJ, Kent MA, El-Shahat E, Wang H, Tan J, White R, et al. Central and peripheral renin-angiotensin systems in ouabain-induced hypertension. Am J Physiol Heart Circ Physiol 2006; 291: H624-H630.
16. Di Filippo C, Filippelli A, Rinaldi B, Piegari E, Esposito F, Rossi F, et al. Chronic peripheral ouabain treatment affects the brain endothelin system of rats. J Hypertens 2003; 21: 747-753.
17. Padilha AS, Rossoni LV, Xavier FE, Vassallo DV. Ouabain at nanomolar concentration promotes synthesis and release of angiotensin II from the endothelium of the tail vascular bed of spontaneously hypertensive rats. J Cardiovasc Pharmacol 2004; 44: 372-380.
18. Vassallo PF, Stefanon I, Rossoni LV, Franca A, Vassallo DV. Small doses of canrenone block the effects of ouabain on the mechanical activity of the heart and vessels of the rat. J Cardiovasc Pharmacol 1998; 32: 679-685.
19. +/K(+)-ATPase in human placental membranes and in erythrocytes. J Cardiovasc Pharmacol 2003; 42: 32-36.
20. Xavier FE, Davel AP, Fukuda LE, Rossoni LV. Chronic ouabain treatment exacerbates blood pressure elevation in spontaneously hypertensive rats: the role of vascular mechanisms. J Hypertens 2009; 27: 1233-1242.
21. Wasserstrom JA, Aistrup GL. Digitalis: new actions for an old drug. Am J Physiol Heart Circ Physiol 2005; 289: H1781-H1793.
22. Blaustein MP, Zhang J, Chen L, Hamilton BP. How does salt retention raise blood pressure? Am J Physiol Regul Integr Comp Physiol 2006; 290: R514-R523.
23. Bauer N, Muller-Ehmsen J, Kramer U, Hambarchian N, Zobel C, Schwinger RH, et al. Ouabain-like compound changes rapidly on physical exercise in humans and dogs: effects of beta-blockade and angiotensin-converting enzyme inhibition. Hypertension 2005; 45: 1024-1028.
24. Zhang J, Leenen FH. AT(1) receptor blockers prevent sympathetic hyperactivity and hypertension by chronic ouabain and hypertonic saline. Am J Physiol Heart Circ Physiol 2001; 280: H1318-H1323.
25. Huang BS, Huang X, Harmsen E, Leenen FH. Chronic central versus peripheral ouabain, blood pressure, and sympathetic activity in rats. Hypertension 1994; 23: 1087-1090.
26. 2+ transporters in arterial smooth muscle from ouabain-induced hypertensive rats. Am J Physiol Heart Circ Physiol 2010; 298: H263-H274.
27. Finotti P, Palatini P. Canrenone as a partial agonist at the digitalis receptor site of sodium-potassium-activated adenosine triphosphatase. J Pharmacol Exp Ther 1981; 217: 784-790.
28. Manunta P, Hamilton BP, Hamlyn JM. Structure-activity relationships for the hypertensinogenic activity of ouabain: role of the sugar and lactone ring. Hypertension 2001; 37: 472-477.
29. Ward SC, Hamilton BP, Hamlyn JM. Novel receptors for ouabain: studies in adrenocortical cells and membranes. Hypertension 2002; 39: 536-542.
30. Huang BS, Leenen FH. Sympathoexcitatory and pressor responses to increased brain sodium and ouabain are mediated via brain ANG II. Am J Physiol 1996; 270: H275-H280.
31. Huang BS, Ganten D, Leenen FH. Responses to central Na(+) and ouabain are attenuated in transgenic rats deficient in brain angiotensinogen. Hypertension 2001; 37: 683-686.
32. Weir MR, Dzau VJ. The renin-angiotensin-aldosterone system: a specific target for hypertension management. Am J Hypertens 1999; 12: 205S-213S.